Charles W. Federico

Mr. Charles W. Federico has over 40 years of experience in the medical device industry. Charlie was the former Chairman of the Board, Lead Director, Compensation & Governance Committee Chairman and Audit Committee Member for MAKO Surgical Group, which was acquired by Stryker (SYK) for $1.65B in 2013.

Prior to Charlie’s role with MAKO, he served as President and Chief Executive Officer of Orthofix International N.V., a global diversified medical device company, from 2001 to 2006. He served as President of Orthofix Inc. from 1996 to 2001. From 1985 to 1996, he served as the President and General Manager at Smith & Nephew Endoscopy (formerly Dyonics, Inc.). From 1981 to 1985, he served as the Vice President of Dyonics and served as its Director of Marketing and General Manager. Additionally, Mr. Federico held various management and marketing positions at General Foods Corporation, Air Products Corporation, Puritan Bennett Corporation and LSE Corporation.

Charlie currently serves as Co-Chairman of the Board and Independent Committee Chairman for LENSAR, an Ophthalmology laser technology and medical device company. He is a current Board Advisor to BioFuse Medical Technologies. Charlie’s previous Board member roles include Power Medical Interventions, Orthofix International, BioMimetic Therapeutics, Alveolus, SRI Surgical Express and OrthoRx. He also served on the Board of Trustees of the Orthopedic Research and Education Foundation, the American Sports Medicine Institute, and as an Advisory Member to the School of Biomedical Engineering and Science at Virginia Tech and Wake Forest University. Mr. Federico received a B.S. in Marketing from Fordham University.